MedPacto, Inc. (KOSDAQ:235980)
South Korea · Delayed Price · Currency is KRW 3,145.00
-45.00 (-1.41%)
Jun 30, 2026, 3:30 PM KST
MedPacto Market Cap
MedPacto has a market cap or net worth of 107.8 billion as of June 30, 2026. Its market cap has decreased by -13.48% in one year.
Market Cap
107.80B
Enterprise Value
71.63B
Revenue
4.79B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,145.00
Market Cap Chart
Since December 19, 2019, MedPacto's market cap has decreased from 362.50B to 107.80B, a decrease of -70.26%. That is a compound annual growth rate of -16.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 107.80B | -52.92% |
| Dec 30, 2025 | 228.96B | 50.62% |
| Dec 30, 2024 | 152.01B | -37.48% |
| Dec 28, 2023 | 243.12B | -48.17% |
| Dec 29, 2022 | 469.05B | -60.97% |
| Dec 30, 2021 | 1.20T | -49.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioneer | 160.54B |
| JETEMA, | 158.66B |
| Macrogen | 126.74B |
| NeoImmuneTech | 124.57B |
| Genexine | 104.60B |
| Amicogen | 103.28B |
| Vaxcell-Bio Therapeutics | 92.10B |
| CG Invites | 78.28B |